Open AccessA Meta-Analysis of Association between Remdesivir and Mortality among Critically-Ill COVID-19 Patients
Author(s) -
Aminah Abdul Razzack,
Syed Adeel Hassan,
Sai Kumar Reddy Pasya,
Greeshma Erasani,
Sham Kumar,
Dario Missael Rocha-Castellanos,
Alfonso López-Méndez,
Sarah Abdul Razzack
Publication year - 2021
Publication title -
infection and chemotherapy/gam'yeom gwa hwahag yo'beob/infection and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.724
H-Index - 26
eISSN - 2092-6448
pISSN - 1598-8112
DOI - 10.3947/ic.2021.0060
Subject(s) - medicine , odds ratio , confidence interval , meta analysis , mortality rate , critically ill , medline , intensive care medicine , emergency medicine , political science , law
The World Health Organization guidelines did not make a recommendation on use of remdesivir based on disease severity. Little is known regarding effectiveness of remdesivir in critically ill coronavirus disease 2019 (COVID-19) patients. This has led to a state of dilemma for doctors leaving them skeptical of whether they should continue to recommend the drug or not.